Recombinant soluble fragment (aa 95-281) of human TRAIL.
Conjugation:
RPE
Alternative Names:
Apo-2 ligand,Apo-2L,APO2L,CD253,chemokine tumor necrosis factor ligand superfamily member 10,TL2,TNF-related apoptosis inducing ligand TRAIL,TNF-related apoptosis-inducing ligand,TNLG6A,TRAIL,tumor necrosis factor (ligand) family, member 10,tumor necrosis factor (ligand) superfamily, member 10,tumor necrosis factor apoptosis-inducing ligand splice variant delta,tumor necrosis factor ligand 6A,tumor necrosis factor ligand superfamily member 10,tumor necrosis factor superfamily member 10.
Cytokine that binds to TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and possibly also to TNFRSF11B/OPG (PubMed:26457518, PubMed:10549288). Induces apoptosis. Its activity may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and TNFRSF11B/OPG that cannot induce apoptosis.
The reagent is provided in phosphate buffered saline (PBS) containing 15 mM sodium azide and 0.2% (w/v) high-grade protease free Bovine Serum Albumin (BSA) as a stabilizing agent.
